Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
CorMedix
CorMedix
(CRMD)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Defencath
Heparin
,
Taurolidine
2023-11-15
2024-2042
Myocardial infarction
,
Pulmonary embolism
,
Postoperative complications
,
Thromboembolism
,
Cerebral infarction
,
Coronary thrombosis
,
Unstable angina
,
Thrombophlebitis
,
Migraine disorders
,
Pain
,
Ventricular tachycardia
,
Orthostatic hypotension
,
Cardiac arrhythmias
,
Cluster headache
,
Postpartum hemorrhage
,
Xerostomia
,
Burns
,
Esophageal diseases
,
Ventricular fibrillation
,
Ventricular premature complexes
,
Mouth diseases
,
Paroxysmal tachycardia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Heparin
chronic kidney failure
,
renal insufficiency
,
sepsis
,
infections
,
communicable diseases
,
catheter-related infections
Taurolidine
central nervous system neoplasms
,
nervous system neoplasms
,
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
periodontitis
,
neoplasms
,
renal insufficiency
,
vascular patency
,
parenteral nutrition
,
infections
,
sepsis
,
catheter-related infections
,
communicable diseases
,
chronic kidney failure
,
bacteremia
,
thrombosis
,
renal dialysis
,
central venous catheters
,
home parenteral nutrition
,
catheters
,
equipment and supplies
,
preconception care
,
oncogenes
,
intestinal failure
Heparin sodium
chronic kidney failure
,
renal insufficiency
,
sepsis
,
infections
,
communicable diseases
,
catheter-related infections
Corticorelin
healthy volunteers/patients
,
multiple myeloma
,
plasma cell neoplasms
,
thrombosis
,
factor xi deficiency
,
heart failure
,
kidney diseases
,
atrial fibrillation
,
chronic kidney failure
,
renal insufficiency
,
hepatitis c
,
venous thromboembolism
,
thromboembolism
Nepidermin
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
healthy volunteers/patients
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
recurrence
,
triple negative breast neoplasms
,
kidney neoplasms
,
fallopian tube neoplasms
,
carcinoma
,
prostatic neoplasms
,
neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
lymphoma
,
non-small-cell lung carcinoma
,
lung neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
breast neoplasms
,
non-hodgkin lymphoma
,
hypertension
,
essential hypertension
,
castration-resistant prostatic neoplasms
,
melanoma
,
b-cell lymphoma
,
macular edema
,
edema
,
erectile dysfunction
,
large b-cell lymphoma diffuse
,
macular degeneration
,
infections
,
communicable diseases
,
trichuriasis
,
hookworm infections
,
ancylostomiasis
,
stroke
,
embolism
,
embolic stroke
,
pharyngitis
,
common cold
,
low back pain
,
back pain
,
acute coronary syndrome
,
syndrome
,
hypersensitivity
,
venous thromboembolism
,
thromboembolism
,
gastrointestinal stromal tumors
,
atrial fibrillation
,
glioblastoma
,
acne vulgaris
,
dysmenorrhea
,
pneumonia
,
bacterial pneumonia
,
neoplasm metastasis
,
thyroid neoplasms
,
thyroid diseases
,
retinal diseases
,
wet macular degeneration
,
retinal degeneration
,
eye diseases
,
heart failure
,
exanthema
Neutrolin
chronic kidney failure
,
renal insufficiency
,
sepsis
,
infections
,
communicable diseases
,
catheter-related infections
,
thrombosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use